Pharma Universalis

Herent ·KBO/BCE: BE 1004.253.371

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	28-05-2026	64 d early	2026-00124666
31-12-2024	31-07-2025	09-07-2025	22 d early	2025-00249883

Metric	This company	Sector median	Position in the sector
Solvency	73.1%	51.1%	better than 69% of 1081 sector peers
Net result	€46k	€24k	better than 67% of 1081 sector peers
Equity	€94k	€51k	better than 67% of 1082 sector peers
Gross operating margin	€60k	€45k	better than 58% of 1081 sector peers
Total assets	€129k	€116k	better than 54% of 1082 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€129k
Fixed assets	21/28	€5k
Formation expenses	20	€0
Tangible fixed assets	22/27	€5k
Current assets	29/58	€124k
Amounts receivable within one year	40/41	€10k
Cash & bank	54/58	€112k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€129k
Equity	10/15	€94k
Contributions / capital	10/11	€5k
Reserves	13	€89k
Amounts payable	17/49	€35k
Amounts payable within one year	42/48	€34k
Trade debts payable within one year	44	€39
Income statement
Gross operating margin	9900	€60k
Operating result	9901	€58k
Financial charges	65	€101
Result before taxes	9903	€58k
Income taxes	67/77	€12k
Net result for the period	9904	€46k
Result to be appropriated	9905	€46k

Summary

Parcel (capakey)	Region	Area	Buildings	Height / fl.
23020D0369/00A000	Flanders	1,263 m²	1 · 286 m²	7.4 m
24423G0079/00D002	Flanders	801 m²	1 · 166 m²	9.4 m · 2 fl.